Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 2566) has announced that an extraordinary general meeting will take place on December 22, 2025, at 2:00 p.m., in Conference Room 3, No. 23, Eighth Street, Baiyang Street, Qiantang District, Hangzhou, Zhejiang Province, PRC.
The meeting agenda includes granting authorization to the Board and its delegated persons to handle matters related to the H Share Full Circulation, considering and approving the proposed H Share Full Circulation, and reviewing the resignation as well as the proposed appointment of a non-executive Director.
According to the announcement, the register of members for H Shareholders will be closed from December 17 to December 22, 2025, inclusive. Shareholders and proxies are requested to pay close attention to the official procedures and deadlines, including completing and returning meeting proxy forms within the specified timeframe. The meeting results will be published on the websites of The Stock Exchange of Hong Kong Limited and the company after voting by poll.
Comments